Skip to NavigationSkip to content

ICON makes two senior appointments

Published on: 21/05/12

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research.

It has also appointed Dr Pui Leung as its new senior clinical research physician, in ICON’s development solutions division.

Dr Anton comes to ICON with over 25 years of experience international epidemiologic, health economic, and outcomes research, and other market access initiatives.

She joins ICON from Boehringer Ingelheim, where she was director of US medical outcomes research and registries.

In this role, Dr Anton provided strategic approach, design and analytic guidance for comparative effectiveness research, epidemiologic studies and health technology assessment within their medical outcomes research and registries division. 

Prior to Boehringer Dr Anton directed health economic, epidemiologic and outcomes research efforts across therapeutic areas at Bristol-Myers Squibb.

Dr Leung joins ICON with over 23 years of hospital and pharma industry experience in a variety of medical specialties including diabetes, endocrinology and general medicine.

Prior to ICON, Dr Leung gained 10 years of experience as a senior Phase I clinical research physician in two UK CROs, and has been principal investigator in many trials with a variety of different study designs including First in Human studies.

Before joining the pharma industry in 2002, Dr Leung spent 13 years as a hospital physician in the NHS.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches